ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021
Citation
Catherine Tran, Clayton Chiu, Allen C Cheng, Nigel W Crawford, Michelle L Giles, Kristine K Macartney, Christopher C Blyth on behalf of the Australian Technical Advisory Group on Immunisation
Communicable Diseases Intelligence, 2021 October 28;45. DOI: https://doi.org/10.33321/cdi.2021.45.60
Abstract
The Australian Technical Advisory Group on Immunisation (ATAGI) 2021 Annual Statement on Immunisation is the first publication in this series. It highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases (VPDs) in Australia in 2020. It also signals ATAGI’s priority actions for addressing key issues for 2021 and beyond.
Summary
In 2020, many immunisation issues were shaped by the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 control measures contributed to lower rates of many VPDs in Australia. Preparation also began for Australia’s COVID-19 immunisation program, which commenced in February 2021.
Related Research Areas
- Public health research